Mesa Laboratories (MLAB) Amortization of Deferred Charges (2017 - 2024)

Mesa Laboratories has disclosed Amortization of Deferred Charges across 8 years of filings, most recently posting $234000.0 for Q1 2024.

• Amortization of Deferred Charges for Q1 2024 came in at $234000.0, up 2.63% year-over-year; the trailing twelve-month figure through Mar 2024 was $926000.0 (up 2.09% YoY), and the FY2025 annual result was $990000.0, up 6.91% from the prior year.
• Amortization of Deferred Charges came in at $234000.0 for Q1 2024 at Mesa Laboratories, up from $231000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $1.4 million in Q1 2021 to a low of $221000.0 in Q2 2021.
• The 5-year median for Amortization of Deferred Charges is $231000.0 (2023), against an average of $563000.0.
• Across the five-year window, Amortization of Deferred Charges advanced 4.71% in 2020 and sank 83.61% in 2022, its largest moves.
• Mesa Laboratories' Amortization of Deferred Charges stood at $1.4 million in 2020, then tumbled by 73.4% to $361000.0 in 2021, then plunged by 37.12% to $227000.0 in 2022, then climbed by 1.76% to $231000.0 in 2023, then advanced by 1.3% to $234000.0 in 2024.
• The last three Amortization of Deferred Charges figures came in at $234000.0 (Q1 2024), $231000.0 (Q4 2023), and $231000.0 (Q3 2023), per Business Quant data.